期刊文献+

4-(4-氟苯基)-6-异丙基-2-(N-甲基-N-甲磺酰胺基)嘧啶-5-羧酸甲酯的合成 被引量:2

Synthesis of 4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-carboxylate
暂未订购
导出
摘要 目的合成罗苏伐他汀的关键中间体 4 (4 氟苯基 ) 6 异丙基 2 (N 甲基 N 甲磺酰胺基 )嘧啶 5 羧酸甲酯。方法以异丁酰乙酸甲酯为起始原料 ,经与对氟苯甲醛缩合、S 甲基异硫脲硫酸盐环合、高锰酸钾氧化 ,再经甲胺基、甲磺酰基取代合成目标化合物。结果 5步反应总收率为2 5 0 %。结论改进了合成路线 。 Aim Synthesis the key intermediate of rosuvastatin 4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-carboxylate.Method Synthesized from methyl isobutyrylacetate by condensation with 4-fluorobenzaldehyde,cylization with S-methylisothiourea sulfate,oxygenation by potassium permanganate,and substitution by methylamine and methanesulfonyl chloride respectively.Result The total yield of five steps is 25.0%.Conclusion Improve the synthetic methods and it is available to the synthesis of rosuvastatin.
出处 《中国药物化学杂志》 CAS CSCD 2004年第3期148-149,157,共3页 Chinese Journal of Medicinal Chemistry
关键词 药物化学 制备 化学合成 他汀 HMG-COA还原酶 medicinal chemistry preparation chemical synthesis statin HMG-CoA reductase
  • 相关文献

参考文献3

  • 1Masamichi Watanabe,Haruo Koike,Teruyuki Ishiba,et al.Synthesis and biological activity of methanesulfonamide pyrimidine-and N-methanesulfonyl pyrrole-substituted 3,5-dihydroxy-6-heptenoates,a novel series of HMG-CoA reductase inhibitors[J].Bioorg Med Chem
  • 2Kentaro Hiral,Teruyuki Ishiba,Haruo Koike,et al.Pyrimidine derivative[P].US:5260440,1993-11-09.
  • 3Rolf Angerbauer,Peter Fey,Walter Hübsch.7-(Polysubstituted pyridyl)-rept-6-endates useful for treting hyperproteinaemia lipoproteinaemia or arteriosclerosis[P].US:5169857,1992-12-08.

同被引文献15

  • 1封宇飞,雷静,吕俊玲,孙春华.新型降酯药——罗伐他汀[J].中国临床药理学杂志,2004,20(3):234-236. 被引量:2
  • 2Crabb JN, Horbury J, Taylor NP. Improved production of rosuvastatin calcium salt[P]. WO: 2004108691, 2004-12-16. (CA 2005, 142: 56338)
  • 3Hirai K, Ishiba T, Koike H, et al. Pyrimidine derivatives [P].EP: 521471, 1991-01-07. (CA 1993, 118: 254949)
  • 4Quirk J, Thornton M, Kirkpatrick P. Rosuvastatin calcium [J]. Nat Rev Drug Discov, 2003, 2 (10): 769-770.
  • 5Watanabe M, Koike H, Ishiba T, et al. Synthesis and biological activity of methanesulfonamide pyrimidine- and Nmethanesulfonyl pyrrole-substituted 3,5-dihydroxy-6-heptenoates, a novel series of HMG-CoA reductase inhibitors [J]. Bioorg Med Chem, 1997, 5 (2): 437-444.
  • 6Nicole E, Yvonne R. Process for the preparation of pyrimidine derivatives[P]. WO: 2004103977, 2004-12-02. (CA 2005, 142: 23301)
  • 7Konoike T, Araki Y. Practical synthesis of chiral synthons for the preparation of HMG-CoA reductase inhibitors [J]. J Org Chem, 1994, 59(25): 7849-7854.
  • 8Carswell CI, Plosker GL, Jarvis B. Josuvastatin [J]. Drugs,2002, 62 (14): 2075-2085.
  • 9Matsushita A, Oda M, Kawachi Y, et al. Preparation of aminopyrimidine compounds [P]. WO: 2003006439, 2003-01-23. (CA 2003, 138: 122651)
  • 10Hirai K, Ishiba T, Koike H, et al. Pyrimidine derivatives [P].US: 5260440, 1993-11-09. (CA 1993, 118: 254949)

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部